Publications and Presentations

Category:

Grewal et al - Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis
Click to View
Alex S. Willoughby - Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion
Click to View
Peter A. Campochiaro - Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study
Click to View
Campochiaro, P., Wykoff, C., Brown, C. - Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study
Click to view
Michael Singer, MD - Tanzanite Phase 2 Retinal vein occlusion (RVO) trial
Click to view
Wykoff C. Durability of Suprachoroidal Triamcinolone Acetonide in Combination with Aflibercept in the Management of Retinal Vein Occlusion: 9-Month Analysis of the TANZANITE Phase 2 Trial and Extension Study
Click to view
Brown D. Suprachoroidal Triamcinolone Acetonidewith Intravitreal Aflibercept For Retinal Vein Occlusion: Phase 2 Results –TANZANITE study
Click to view

As a courtesy to our stakeholders, Clearside Biomedical, Inc. lists posters and presentations delivered on, or related to our programs at various medical meetings and in various publications. Some of these materials may be authored by individuals outside the Company with or without funding from Clearside. Please note that the studies, data, opinions, and other disclosures made by these individuals may not fully reflect the status of the Clearside programs. Clearside Biomedical does not by its reference above or distribution necessarily imply its endorsement of or concurrence with such information, conclusions, or recommendations.